Detalhe da pesquisa
1.
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
Blood
; 138(3): 273-282, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292325
2.
Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older.
Cancer
; 127(22): 4233-4239, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374445
3.
Veno-occlusive disease risk in pediatric patients with acute myeloid leukemia treated with gemtuzumab ozogamicin before allogeneic hematopoietic cell transplantation.
Pediatr Blood Cancer
; 68(8): e29067, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33871892
4.
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
Cancer
; 126(23): 5077-5087, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965680
5.
Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?
Haematologica
; 105(2): 407-413, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31101756
6.
Use of Person Locator Service to Facilitate Immunization Information System-Based Adolescent Reminder Project.
J Public Health Manag Pract
; 26(2): 148-152, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31995547
7.
Bone Marrow versus Peripheral Blood from Unrelated Donors for Children and Adolescents with Acute Leukemia.
Biol Blood Marrow Transplant
; 24(12): 2487-2492, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142417
8.
The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia.
Haematologica
; 102(5): 941-947, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126967
9.
Donor and recipient sex in allogeneic stem cell transplantation: what really matters.
Haematologica
; 101(10): 1260-1266, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27354023
10.
JAK2 V617F mutation and associated chromosomal alterations in primary and secondary myelofibrosis and post-HCT outcomes.
Blood Adv
; 7(24): 7506-7515, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011490
11.
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease.
J Clin Oncol
; 41(12): 2227-2237, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623245
12.
Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population.
Transplant Cell Ther
; 28(6): 325.e1-325.e7, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302009
13.
Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.
Transplant Cell Ther
; 28(10): 696.e1-696.e7, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798233
14.
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
Lancet Haematol
; 8(3): e185-e193, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482113
15.
Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Donor Transplantation.
Transplant Cell Ther
; 27(11): 926.e1-926.e10, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407489
16.
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors.
Blood Adv
; 5(4): 975-983, 2021 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33576783
17.
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR.
J Clin Oncol
; 38(14): 1518-1526, 2020 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32031876
18.
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.
Blood Adv
; 3(19): 2836-2844, 2019 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582392
19.
Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide.
Blood Adv
; 2(3): 299-307, 2018 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29440002
20.
Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?
Blood Adv
; 2(11): 1180-1186, 2018 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29794073